Add time:07/16/2019         Source:sciencedirect.com

AimUlcerative colitis and Crohn's disease are two important chronic Inflammatory bowel diseases (IBD) characterized by prominent intestinal inflammation. Probiotics are the bacteria that promote the host health by its immunomodulatory activity. The present study investigated the correlation between in vitro adhesion and immunomodulatory properties, and to assess the therapeutic potential of Bifidobacterium bifidum 231 (BIF 231), a new strain of probiotic in ulcerative colitis in rats.

We also recommend Trading Suppliers and Manufacturers of Acid Blue 231 (cas 12234-67-2). Pls Click Website Link as below: cas 12234-67-2 suppliers